- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
300759
SHZ
Week ended 07 Aug 2026
Weekly Investor Report
Pharmaron Beijing Co., Ltd. · Healthcare · Biotechnology
Latest close
45.28 CNY
23.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 52.6% above the Trend Line and sits at 99.9% of its 52-week range. The latest completed week returned 23.0%, after a 33.4% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high.
Setup score
62
out of 100
Latest Close
45.28 CNY
7 Aug 2026
1W Return
23.0%
latest completed week
4W Return
33.4%
short-term follow-through
12W Return
70.3%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- Next-week expectancy is negative at 44.77% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 5 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
23.0%
Latest completed week; four-week move 33.4%.
Indicator stack
29/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.77%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
6 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 52.6% above the Trend Line and sits at 99.9% of its 52-week range. The latest completed week returned 23.0%, after a 33.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3612-week average 0.14
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.36Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers
No recent accumulation markers. 5 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 33.4% over four weeks, 70.3% over 12 weeks, and 50.4% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.67Latest activity-pressure read.
Pressure change2744.9%Four-week change in activity pressure.
Leadership43.99Latest relative-leadership reading.
RS change1168.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 6 relevant articles.
2 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.0%Distance below the 52-week high.
13-week volatility9.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+23.0%Week of 7 Aug.
Worst week-8.7%Week of 5 Jun.
Latest week+23.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains6
Flat weeks0
Modest losses7
Sharp losses6
Recent vol9.4%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank1 / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Biotechnology
4-week rank2 / 100
Group average4.5%
Trend breadth15.0%
Trend15.0%active weekly trend signals
MD37.0%positive activity pressure
RS32.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis26/100Latest 12-week confirmation: trend 2/12, activity pressure 4/12, relative leadership 5/12.
Activity pressure 0.36; 5 reversal markers Next-Week ExpectancyNegative 44.77%Next-week expectancy is negative with a 44.77% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 6 relevant articles.
ETFs Investing in Pharmaron Beijing Co., Ltd. Class H Stocks Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 45.28 CNY | 23.0% | 29.67 CNY | 26.68 CNY | 1.67 | 43.99 | 376.9M | On |
| 31 Jul 2026 | 36.80 CNY | -4.5% | 29.11 CNY | 26.55 CNY | 1.63 | 23.80 | 302.4M | On |
| 24 Jul 2026 | 38.53 CNY | 8.6% | 28.86 CNY | 26.48 CNY | 1.29 | 27.80 | 498.3M | Off |
| 17 Jul 2026 | 35.48 CNY | 4.5% | 28.56 CNY | 26.39 CNY | 0.68 | 18.67 | 641.4M | Off |
| 10 Jul 2026 | 33.94 CNY | 15.5% | 28.38 CNY | 26.32 CNY | -0.06 | 3.47 | 407.1M | Off |
| 3 Jul 2026 | 29.38 CNY | 12.3% | 28.22 CNY | 26.27 CNY | -0.81 | -13.66 | 55.7M | Off |
| 26 Jun 2026 | 26.15 CNY | 15.9% | 28.20 CNY | 26.28 CNY | -1.23 | -24.31 | 76.8M | Off |
| 19 Jun 2026 | 22.56 CNY | 1.5% | 28.28 CNY | 26.30 CNY | -1.42 | -36.06 | 135.5M | Off |
| 12 Jun 2026 | 22.23 CNY | -3.0% | 28.58 CNY | 26.36 CNY | -1.41 | -33.09 | 70.0M | Off |
| 5 Jun 2026 | 22.92 CNY | -8.7% | 28.89 CNY | 26.40 CNY | -1.22 | -33.09 | 27.9M | Off |
| 29 May 2026 | 25.10 CNY | -3.2% | 29.24 CNY | 26.46 CNY | -1.02 | -28.48 | 120.8M | Off |
| 22 May 2026 | 25.93 CNY | -2.5% | 29.48 CNY | 26.49 CNY | -0.66 | -26.63 | 128.9M | Off |
| 15 May 2026 | 26.59 CNY | -2.3% | 29.62 CNY | 26.51 CNY | -0.46 | -24.96 | 157.3M | Off |
| 8 May 2026 | 27.21 CNY | -7.2% | 29.84 CNY | 26.55 CNY | -0.13 | -23.59 | 125.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.